Status epilepticus: Stadien und Pathophysiologie
Über den Vortrag
Der Vortrag „Status epilepticus: Stadien und Pathophysiologie“ von Roy Strowd, MD ist Bestandteil des Kurses „Anfälle und Epilepsie“.
Quiz zum Vortrag
Which statement is the most accurate with respect to the stages of status epilepticus (SE)?
- Stage 3 is considered refractory SE.
- Stage 1 is characterized by continuous seizure activity.
- Stage 2 is characterized by confusion without seizure activity.
- Stage 4 is characterized by continuous ictal activity on EEG.
- Stage 5 is considered super-refractory SE.
Which statement is the most accurate regarding status epilepticus? (gamma-aminobutyric acid is GABA and N-methyl-D-aspartate is NMDA)
- As the stages progress, the GABA receptors are modified.
- Stage 1 has increased GABA stimulation.
- Stage 1 has decreased NMDA stimulation.
- NMDA receptors are modified as the stages progress.
- There are no changes in either NMDA or GABA receptors.
Which statement is the most accurate with regard to the systemic impact of status epilepticus (SE)?
- If unresolved, SE can lead to cardiopulmonary collapse.
- There is an early increase of parasympathetic tone.
- Cerebral blood flow decreases initially.
- Compensatory mechanisms prevent systemic changes until stage 4.
- There is minimal impact on other organ systems throughout the SE episode.
Which statement is the most accurate with regard to brain chemistry during SE?
- Cerebral oxygen levels begin to fall after 30 minutes.
- There is an initial decrease in blood oxygen levels.
- There is an initial decrease in brain glucose levels.
- There is an initial drop in cerebral blood flow.
- Significant brain damage may occur during the first 30 minutes.
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Status epilepticus: Stadien und Pathophysiologie
Roy Strowd, MD
Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
